GlassScriptPhysician profile
David C Mason
NPI 1093795478
$509.65
in general payments reported to CMS, 2019-2025
17 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.67 · 2021: $42.95 · 2022: $36.89 · 2023: $86.55 · 2024: $167 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $84.53 | 2024 | Inspire |
| Abbott Laboratories | $53.57 | 2022-2025 | Id Now Instrument, Freestyle Libre 2 |
| Eisai INC. | $52.19 | 2025 | |
| Intuitive Surgical, INC. | $44.80 | 2023 | |
| Edwards Lifesciences Corporation | $40.88 | 2024 | Sapien 3 Ultra Resilia |
| Averitas Pharma INC. | $35.56 | 2025 | Qutenza |
| Soleno Therapeutics, INC. | $33.14 | 2025 | Vykat Xr |
| Mylan Specialty L.P. | $24.05 | 2024 | Yupelri |
| Lilly USA, LLC | $21.31 | 2023 | Trulicity, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $19.19 | 2025 | Rexulti |
| Si-Bone, INC. | $17.67 | 2019 | |
| Pfizer INC. | $17.05 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $16.93 | 2022 | |
| Abbvie INC. | $16.26 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.20 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $12.49 | 2021 | |
| Organon LLC | $5.83 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.